Paul Schimmel, Director at aTYR PHARMA INC (LIFE), bought 294,450 shares at $0.54 ($159K) on 2018-11-26, disclosed to the SEC on 2018-11-28.
Open-market purchase of $159k LIFE by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.54 | 147,225 | $80K | 50.0% |
| 2 | $0.54 | 147,225 | $80K | 50.0% |
| Total | $0.54 avg | 294,450 | $159K | 100% |
| Filing → |
| ATYR | BUY | 2024-07-24 | $256K | — | Filing → |
| LIFE | BUY | 2023-05-11 | $450K | — | Filing → |
| LIFE | BUY | 2021-09-22 | $2.0M | — | Filing → |